News

Deal Announcements

Anaphore Accepts $13 Million Venture Capital Financing

Tuesday, May 19, 2009 5:49:00 AM PDT | VentureDeal Staff
San Diego, California  --  Biotechnology company Anaphore has secured $13 million in its first round of venture capital investment.

Anaphore is focused on developing treatments for immune-based diseases and was created through the acquisition of Borean Pharma ApS.

Investors in the round included SR One, Merck Serono Ventures and Aravis Ventures. The company did not disclose how the funding proceeds would be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1